The current P/E ratio for Vericel stock as of Jun 3, 2026 is 80.79. This is calculated based on the current EPS of $0.43 and the stock price of $34.74 per share. The PE ratio has decreased by 47% from the past four quarters average of 152.2.
The average historical PE ratio of Vericel for the last six years is 1056.04. The current price-to-earnings ratio of 80.79 is 92% less than the historical average. In the past six years, VCEL's PE ratio reached its highest point in the Sep 2021 quarter at 4,880, when the stock price was $48.8 and the EPS was $0.01. The lowest point was recorded in the Mar 2026 quarter, when it reached 74.81 with a price of $32.17 and an EPS of $0.43.
Maximum annual decrease: -58.27% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 109.12 | -58.27% | $36.01 | $0.33 |
| 2024 | 261.48 | N/A | $54.91 | $0.21 |
| 2023 | N/A | N/A | $35.61 | -$0.07 |
| 2022 | N/A | N/A | $26.34 | -$0.35 |
| 2021 | N/A | N/A | $39.3 | -$0.16 |
| 2020 | 514.67 | N/A | $30.88 | $0.06 |
| 2019 | N/A | N/A | $17.4 | -$0.22 |
| 2018 | N/A | N/A | $17.4 | -$0.2 |
| 2017 | N/A | N/A | $5.45 | -$0.52 |
| 2016 | N/A | N/A | $3 | -$1.18 |
| 2015 | N/A | N/A | $2.58 | -$0.97 |
| 2014 | N/A | N/A | $3.04 | -$2.23 |
| 2013 | N/A | N/A | $3.23 | -$6.95 |
| 2012 | N/A | N/A | $25.2 | -$16.25 |
| 2011 | N/A | N/A | $36.4 | -$10.18 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 74.81 | -31.44% | $32.17 | $0.43 |
| Dec 2025 | 109.12 | -9.85% | $36.01 | $0.33 |
| Sep 2025 | 121.04 | -60.18% | $31.47 | $0.26 |
| Jun 2025 | 303.93 | -65.94% | $42.55 | $0.14 |
| Mar 2025 | 892.4 | 241.29% | $44.62 | $0.05 |
| Dec 2024 | 261.48 | -56.68% | $54.91 | $0.21 |
| Sep 2024 | 603.57 | -86.84% | $42.25 | $0.07 |
| Jun 2024 | 4,588 | N/A | $45.88 | $0.01 |
| Mar 2024 | N/A | N/A | $52.02 | $0 |
| Dec 2023 | N/A | N/A | $35.61 | -$0.07 |
| Sep 2023 | N/A | N/A | $33.52 | -$0.22 |
| Jun 2023 | N/A | N/A | $37.57 | -$0.28 |
| Mar 2023 | N/A | N/A | $29.32 | -$0.36 |
| Dec 2022 | N/A | N/A | $26.34 | -$0.35 |
| Sep 2022 | N/A | N/A | $23.2 | -$0.38 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, VCEL's PE ratio is lower than the 3, 5 and 10-year averages.
Vericel's P/E of 80.79 is above the Healthcare sector and the industry average. Looking at its Healthcare sector average of 23.02, Vericel's P/E is 251% higher.
When compared to its peer stock RPRX, VCEL's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| RPRX Royalty Pharma plc | 28.96 | $31.85B |
| VCEL Vericel Corp | 82.91 | $1.82B |
| NEOG Neogen Corp | N/A | $1.98B |
The price to earnings ratio for VCEL stock is 80.79 as of Jun 3, 2026.
The average PE ratio for VCEL stock over the past 3 years is 869.29.
The average PE ratio for VCEL stock over the past 5 years is 1209.69.
Over the last six years, the quarterly PE ratio reached a historic high of 4,880 in the Sep 2021 quarter.
The current price to earnings ratio of VCEL is 92% lower than the 6-year historical average.
VCEL's PE ratio of 80.79 is considered high because the company's stock price is trading at a higher multiple of earnings.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jun 3, 2026), Vericel's stock price is $34.74. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.43. Therefore, Vericel's price to earnings ratio for today is 80.79. PE RATIO(80.79) = STOCK PRICE($34.74) / TTM EPS($0.43)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.